Company hired many more people in that period, more so recently overseas in the US as well as domestically, clearly indicating confidence that the money spent was making sense in the broader context towards human trials and commercial outcomes and broadening the pipeline.
When presenting last year in the US, management opted to collect further data, toxicity included, which would pave way to partnerships talks on a different level. Rohan mentioned a year ago at the last AGM that the board anticipates to tap into both, domestic and US financial markets. The long positioning and broker activity which followed points to the domestic finance play being around the corner. The GLP data in conjunction the IND submission in this quarter mark the point of commitment in several other licence deals in the industry.
Current depressed level with active broker suppression is a typical precursor of such events to occur. A breakthrough event in this quarter and early next year is palpable, all IMO
PYC Price at posting:
6.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)